Asset Details
Do you wish to reserve the book?
Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation
Do you wish to request the book?
Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation
2022
Overview
Concerns regarding outcomes and early resource utilization are potential deterrents to broader use of kidneys at risk for delayed graft function (DGF). We assessed outcomes specific to kidneys with DGF that required early readmission following transplant. Three groups were identified: 1) recipients with DGF not requiring readmission, 2) recipients with DGF having an isolated readmission, and 3) recipients with DGF requiring ≥2 readmissions. Most recipients either required a single readmission (26.8%,
n
= 247) or no readmission (56.1%,
n
= 517); 17.1% (
n
= 158), had ≥2 readmissions. Recipients requiring ≥2 readmissions were likely to be diabetic (53.8%,
p
= 0.04) and have longer dialysis vintage (
p
= 0.01). Duration of DGF was longer with increasing number of readmissions (
p
< 0.001). There were no differences in patient survival for those with DGF and 0, 1 and ≥2 readmissions (
p
= 0.13). Graft survival, however, was lower for those with ≥2 readmissions (
p
< 0.0001). This remained true when accounting for death-censored graft loss (
p
= 0.0012). Additional subgroup analysis was performed on mate kidneys with and without DGF and mate kidneys, both with DGF, with and without readmissions. For these subgroups, there were no differences in patient or graft survival. As a whole, patients with DGF have excellent outcomes, however, patients with DGF requiring ≥2 readmissions have lower graft survival. A better understanding of recipient variables contributing to multiple readmissions may allow for improvements in the utilization of DGF at-risk kidneys.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
